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The collecting duct of the kidney is composed of two
morphologically and physiologically distinct cell types,
principal and intercalated cells. To better understand
intercalated cell function we generated a transgenic mouse
expressing Cre recombinase under the control of a cell type-
specific promoter. We used 7 kb of the ATP6V1B1 50
untranslated region (B1 promoter), a gene found in the
intercalated cells of the kidney and the male reproductive
tract. We first crossed these B1-Cre transgenic mice with the
ROSA26-loxP-stop-loxP-yellow fluorescent protein reporter
mice to assess the specificity of Cre expression.
Immunohistochemistry and confocal fluorescence
microscopy showed that Cre is selectively active in all
intercalated cells (type A, type B, and non-A/B cells) within
the collecting duct and most cells of the connecting segment.
About half of the principal cells of the connecting segment
also expressed Cre, a pattern also seen in B1-driven
enhanced green fluorescent protein transgenic mice. Cre was
found to be active in the male reproductive tract and at a low
level in limited non-ATP6V1B1 expressing tissues. The B1-Cre
transgenic mice are healthy, breed normally, produce regular
sized litters, and transmit the transgene in Mendelian
fashion. This new cell-specific Cre expressing mouse should
prove useful for the study of intercalated cell physiology and
development.
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The renal collecting duct is important in the regulation of
extracellular volume, osmolality, and pH. It is composed of
two morphologically and physiologically distinct cell types,
that is, principal and intercalated cells (ICs). Principal cells
(PCs) are important in the maintenance of sodium and water
balance, whereas ICs are important in acid–base balance and
maintenance of NaCl balance.1–3 PC-specific gene inactiva-
tion using the AQP2-Cre transgenic mouse has helped
further our understanding of principal function.4–7 To better
understand IC function we generated an IC-specific Cre-
expressing transgenic mouse. We used the same 7 kb of the
ATP6V1B1 promoter that was used to drive expression of
enhanced green fluorescent protein (EGFP)8 to drive
expression of Cre recombinase. Here we describe the
construction of the transgene, generation of the transgenic
mice, and characterization of cellular pattern of expression of
Cre recombinase. We show that the transgenic mice are
healthy, transmit the transgene in a Mendelian fashion, and
express Cre recombinase in all ICs within the collecting duct
of kidney. This novel Cre transgenic mouse line is a new tool
to allow selective inactivation of genes expressed in ICs and
should be of great utility in studying the role of ICs in
collecting duct physiology.
RESULTS
B1-Cre transgenic mice
Approximately 50 pups were generated from pronuclear
injection of the B1-Cre transgene (Figure 1a) into single-cell
embryos; founders were breed onto a C57Bl6/CBA back-
ground. Mice from the F1 generation were breed with the
ROSA26-YFP transgenic mice (Figure 1b), F2 generation were
analyzed for cell-specific Cre activity. Only a single founder
demonstrated the most complete and cell-specific expression
of Cre recombinase, with a single copy of transgene per cell
equivalent (Figure 1c).
B1-Cre transgene expression in kidney and male
reproductive tract
Cryosections from B1-Creþ /, YFPþ / adult mice were used
to examine cell-specific Cre activity. Sections were probed
with antibodies against AQP2, ATP6V1B1, and/or calbindin-
D28K to positively identify PCs, ICs, and the connecting
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tubule (CNT), respectively. Expression was examined in the
CNT, cortical collecting duct (CCD), outer medullary
collecting duct (OMCD), and inner medullary collecting
duct (IMCD). Micrographs are representative of images from
a minimum of 10 sections per kidney from a minimum of
five different transgenic mice.
Figure 2 shows representative fluorescent confocal micro-
graphs of renal sections of the CNT (Figure 2a–c), CCD
(Figure 2d and g), OMCD (Figure 2e and h), and IMCD
(Figure 2f and i) from B1-Cre/YFP-positive mice. Sections
were probed with antibodies against ATP6V1B1 (red) (Figure
2a, d, e, and f), calbindin-D28K (blue) (Figure 2c) and AQP2
(red) (Figure 2g, h, and i) and photomerged with YFP
(green) sections. Results show that all ATP6V1B1-positive
cells expressed YFP and that all AQP2-positive cells in the
CCD, OMCD, and IMCD were negative for YFP. However, at
least 50% of AQP2-positive cells in the CNT were YFP
positive; we observed a similar expression pattern in the
B1-EGFP transgenic mouse.8 These data show that Cre is
active in all ICs and not active in PCs in the CCD, OMCD, and
IMCD; however, Cre is active in about 50% of PCs in CNT.
Cre activity was also examined in the male reproductive
tract. Figure 3 shows a representative fluorescence confocal
micrograph of the epididymis from the B1-Cre/YFP transgenic
probed with antibodies against the ATP6V1B1 (red). Results
show that Cre is active in nearly all ATP6V1B1-positive cells and
in some non-ATP6V1B1-negative cells (p5%).
B1-Cre transgene expression in non-ATP6V1B1-expressing
organs
The degree of non-specific Cre activity was examined in the
major non-ATP6V1B1-expressing organs, that is, brain, large
and small intestine, uterus, liver, stomach, skeletal muscle,
heart, and spleen. Cryosections of organs from B1-Cre/YFP
transgenic mouse were labeled with the nuclear stain
TOPRO3 (red) and imaged by fluorescence confocal micro-
scopy. The degree of nonspecific Cre activity was determined
as the ratio of YFP-positive cells (green) to the total number
of cells (red). We chose this approach because it shows the
number of cells in which Cre is activity at a level sufficient to
cause recombination. Figure 4 shows representative confocal
fluorescence micrographs of representative organs including
the liver (Figure 4a) and uterus (Figure 4d) labeled with
ToPRO 3. Results show that Cre is active in 15.5±3.5,
10.4±1.4, 28.2±2.8, 4.2±2.6% of all cells within the brain,
large intestine, small intestine, and uterus, respectively,
whereas it was not active in the liver, stomach, skeletal
muscle, heart, and spleen. The mechanisms for the
nonspecific Cre activity remain unclear but are likely related
to the site of transgene integration and not the promoter as
we did not observe nonspecific EGFP expression in the B1-
EGFP transgenic mouse.8
DISCUSSION
This study shows that B7 kb of the human ATP6V1B1
promoter drives expression of Cre recombinase in all ICs
within the B1-Cre transgenic mouse kidney at levels sufficient
to cause Cre-mediated recombination. Expression analysis
showed that Cre recombinase was active in all ICs
(ATP6V1B1-positive cells) within the kidney, whereas it was
not active in any other cell type except in about 50% of PCs
within the CNT only. A similar phenomenon was observed in
the B1-EGFP transgene mouse,8 where EGFP was expressed
in about 50% of PCs within the CNT only. Although the
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Figure 1 | Transgene, reporter system and genotyping. Schematic of the (a) B1-Cre transgene, (b) B1-Cre/Rosa26-YFP reporter system,
and (c) genotyping. (a) Approximately, 7 kb of the human ATP6V1B1 50-flanking region or promoter was linked to the Cre recombinase
expression cassette, which included the SV40 polyadenylation signal (CreTag). The location and identification of restriction sites used to
clone the transgene and PCR genotyping primers are shown in reference to the translational start site (þ 1) of Cre recombinase cassette.
XhoI and NotI were used to remove the transgene from the plasmid backbone. (b) Mice carrying the B1-Cre transgene were bred with mice
carrying the ROSA26-loxP-stop-loxP-YFP reporter gene. Cells expressing the B1-Cre transgene will appear ‘yellow’ under the fluorescence
microscope as a result of Cre-mediated excision of ‘Stop’ between the loxP sites and activation of YFP expression. (c) PCR genotyping of tail
DNA from two F1 offspring from founder line 45 for the B1-Cre transgene. Normal mouse DNA (100 ng) was spiked with 0, 1, 10, and 100
copies per cell equivalent of the purified transgene DNA (left) and 100 ng of tail DNA from two F1 offspring from line 45 (right) were
amplified by PCR using primers specific for the B1-Cre transgene.
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precise mechanism for the nonspecific Cre activity in CNT
PCs is not known, we hypothesize that it is due to some
intrinsic and unique property of cells in the CNT and not the
transgene or its integration site.
Results show Cre is active in most ATP6V1B1-positive
cells within the male reproductive tract and in some non-
ATP6V1B1-positive cells. We also observed minimal non-
specific expression in a few non-ATP6V1B1-expressing
organs, that is, uterus, large intestine, brain, and small
intestine. We hypothesize that the nonspecific Cre activity in
these organs and the male reproductive tract is due to the
integration site and is not the same mechanism responsible
CNT
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IMCDOMCDCCD
CNT CNT
Non A,B
Type A
Figure 2 | Representative fluorescence confocal micrographs of the CNT, CCD, OMCD, and IMCD from B1-Cre/YFP-positive mice.
Cryosections of the CNT, CCD, OMCD, and IMCD were immunostained with antibodies against (a, d, e, f) ATP6V1B1, (b, g, h, i) AQP2, and
(c) calbindin-D28K. Primary antibodies were detected using a donkey anti-rabbit Alexafluor 647 labeled secondary antibody and
pseudocolored red or blue. Images were obtained using a  60 oil-immersion objective and photomerged with those obtained for YFP,
which was pseudocolored green. Arrows show examples of type A and type non-A, non-B-intercalated cells.
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Figure 3 | Fluorescence confocal microscopy of male reproductive tract. Cryosections of the male reproductive tract from the
B1-Cre/YFP transgenic mice were immunostained with antibodies against ATP6V1B1 and imaged by fluorescence confocal
microscopy. Images of the ATP6V1B1 (red) and YFP (green) were photomerged.
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for Cre activity in PCs within the CNT. The nonspecific Cre
activity should be of little or no consequence if the floxed
gene is not present or does not play a significant functional or
developmental function in these organs.
In summary, this B1-Cre transgenic mouse represents the
first that demonstrates IC-specific Cre activity. In this mouse
line, Cre is active in all ICs, that is, type A, type B, and non-
A/B cells. The mice are healthy, breed normally, produce
normal-sized litters, and transmit the transgene in a
Mendelian fashion. Therefore, we believe that this mouse
line can be used to selectively inactivate genes in ICs and
could be important in the study of ICs.
MATERIALS AND METHODS
Construction of the transgene and generation of mice
The ATP6V1B1 promoter-Cre transgene (Figure 1a) was constructed
according to the following. The ATP6V1B1 gene corresponding to
6937 to 196 bp (B7 kb) was cut out from a clone using HindIII,
whereas a fragment of the ATP6V1B1 gene corresponding to 345
to þ 1059 bp was cut out using EcoRI; both were cloned into
pBluescript. Next, a fragment corresponding to 196 to 1 bp was
ligated into the 50 end of CreTag-pBluescript II KSþ using HindIII
and SmaI; the SmaI site was added by PCR. The 7 kb fragment was
cut out and cloned into the 50 end of the p1.4 kb-ATP6V1B1-CreTag
using HindIII; this product was designated as pB1-Cre. The B1-Cre
transgene was isolated using XhoI and NotI and prepared for
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Figure 4 | Fluorescence confocal microscopy of nonrenal organs. Representative fluorescence confocal micrographs of organs from
B1-Cre/YFP-positive mice showing YFP-positive cells in (a, d) liver and uterus that were probed with the nuclear stain (b, e) ToPRO3.
(c and f) Merged micrographs from (a, b) and (d, e), respectively. Images were obtained using a  40 oil-immersion objective. The number
of YFP positive (green) and the total number of cells (red) were counted. (g) Cre expression is shown as the percent of YFP-positive cells
relative to the total number of cells (lower panel). Data represent the mean±s.e.m. from 15 sections per organ, n¼ 5 organs. The scale bar
represents 50 mm.
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injection as previously described.8 Transgenic mice were created by
Xenogen (Cranbury, NJ, USA). Founders were bred onto a mixed
background (C57BL/6CBA). All procedures were performed
according to protocols approved by the University of Utah
Institutional Animal Care and Use Committee. DNA from tail
biopsy specimens (100 ng) was for PCR genotyping using primers
specific for the Cre cassette, that is, CreF (50-CATTACCGGTCGATG
CAACGAG-30) and CreR (50-TGCCCCTGTTTCACTATCCAGG-30).
Immunohistochemistry and image analysis
Tissue sections were probed with either a polyclonal goat anti-AQP2 at
1:500 (sc-9882; Santa Cruz Biotechnology, Santa Cruz CA, USA), and/
or a polyclonal rabbit anti-ATP6V1B1 at 1:500,9 and/or a polyclonal
rabbit anti-calbindin-D28K at 1:20,000 (CB 38a; Swant, Bellinzona,
Switzerland). Primary antibodies were detected using donkey anti-
rabbit or donkey anti-goat immunoglobulin G conjugated to
Alexafluor 555 or Alexafluor 647 (Molecular Probes, Eugene, OR,
USA). Nonrenal organs were co-labeled with the nuclear stain TOPro3
(Sigma-Aldrich, St. Louis, MO, USA) to facilitate cell counting. All
micrographs were obtained using an Olympus FV1000. YFP was
visualized at 514 nm (excitation) and 533 nm (emission), using an
argon laser and variable band-pass filter, antibodies labeled with
Alexafluor 555 or 647 were visualized by exciting at 543 and 633 nm
and collecting emissions at 568 and 669 nm, respectively.
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